We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$473M
AUM Growth
-$74.8M
Cap. Flow
-$60.6M
Cap. Flow %
-12.81%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$128M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$1.1M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$189M

Sector Composition

Rank Sector Weight
1 Healthcare 59.33%
2 Consumer Staples 30.98%
3 Miscellaneous 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$147M 31.08%
+1,630,968
New +$128M
MNST icon
2
Monster Beverage
MNST
$87.5B
$147M 30.98%
19,189,632
– –
STAA icon
3
STAAR Surgical
STAA
$1.14B
$73.2M 15.47%
6,887,095
– –
MNST icon
4
PUT
Monster Beverage
MNST
$87.5B
$45.8M 9.69%
6,000,000
-6,000,000
-50% -$39.4M
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$43.3M 9.15%
17,088,778
+458,434
+3% +$1.1M
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$17.2M 3.63%
817,029
– –
QCOR
7
DELISTED
QUESTCOR PHARMA INC
QCOR
– –
-2,046,660
Closed -$189M

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Broadwood Capital held 7 positions worth $473M, down 14% from $548M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $60.6M in Q3 2014, closing 1 position and reducing 1 holding. Its most notable exit was QUESTCOR PHARMA INC, an estimated $189M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 32% a quarter earlier, followed by Consumer Staples and Miscellaneous.

Against the trend, Broadwood Capital opened a new position in MALLINCKRODT PUBLIC LIMITED COMPANY worth $147M.

  • Broadwood Capital's largest Q3 2014 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,630,968 shares worth $147M.
  • Broadwood Capital added most to Lineage Cell Therapeutics in Q3 2014, an estimated $1.1M increase.
  • Broadwood Capital fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $189M.
  • Broadwood Capital's ten largest holdings make up 100% of its $473M portfolio in Q3 2014.
  • Broadwood Capital opened 1 new position and closed 1 in Q3 2014.
  • Broadwood Capital's portfolio value fell 14% quarter-over-quarter to $473M.

Based on Broadwood Capital's 13F filing for Q3 2014, filed 14 Nov 2014.